XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday.
美國股市漲跌互現，道瓊斯指數週一下跌超過100點。
Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Monday's session.
小鵬公司（紐約證券交易所代碼：XPEV）的股價在週一的交易中大幅上漲。
The company delivered 30,895 vehicles last month, marking an increase of 54% year-over-year and 29% from October.
該公司上個月交付了30,895輛汽車，同比增長54％，比10月份增長29％。
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.
這家總部位於廣州的電動汽車初創公司表示，該公司僅小鵬Mona M03掀背轎跑車的交付量就連續第三個月超過1萬輛。該公司上個月推出的小鵬P7+轎車的交付量也超過了7,000輛。
XPeng shares jumped 6.4% to $12.82 on Monday.
週一，小鵬股價上漲6.4％，至12.82美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易日其他一些上漲的大型股票。
- NovoCure Limited (NASDAQ:NVCR) shares gained 29.9% to $26.04 after the company announced its Phase 3 PANOVA-Trial met its primary endpoint and demonstrated a statistically significant improvement in its median overall survival rate.
- Super Micro Computer, Inc. (NASDAQ:SMCI) surged 22% to $39.83 after the company announced it completed a review by an independent special committee and stated EY's conclusions were not supported by findings.
- Fastly, Inc. (NYSE:FSLY) jumped 17% to $9.92.
- Nebius Group N.V. (NASDAQ:NBIS) shares gained 15.5% to $25.40 after the company announced it entered a $700 million private placement financing agreement with institutional investors.
- Enovix Corporation (NASDAQ:ENVX) gained 15.1% to $10.65.
- Zeta Global Holdings Corp. (NYSE:ZETA) jumped 14.6% to $24.41.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) surged 14.3% to $50.15 after the company announced it signed a global licensee and collaboration agreement with Novartis for its PTC518 Huntington's Disease program.
- Dana Incorporated (NYSE:DAN) gained 14% to $11.39 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $18.
- MINISO Group Holding Limited (NYSE:MNSO) gained 12.9% to $22.60. The company, on Friday, posted first-quarter results.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) climbed 11.3% to $7.87.
- Akso Health Group (NASDAQ:AHG) rose 8.8% to $0.9000.
- Abercrombie & Fitch Co. (NYSE:ANF) gained 8.2% to $161.94.
- Merus N.V. (NASDAQ:MRUS) gained 8% to $48.43 after the company announced it entered into an agreement to exclusively license the right to Ptx the right to commercialize Zenocutuzumab (Zeno) for Nrg1 Fusion-positive cancer in the US.
- The Gap, Inc. (NYSE:GAP) rose 5.7% to $25.63 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $28 to $30.
- NovoCure Limited（納斯達克股票代碼：NVCR）股價上漲29.9％，至26.04美元，此前該公司宣佈其第三階段Panova試驗已達到其主要終點，總體存活率中位數有了統計學上的顯著改善。
- 超級微電腦公司（納斯達克股票代碼：SMCI）上漲22％，至39.83美元，此前該公司宣佈已完成獨立特別委員會的審查，並表示安永的結論沒有得到調查結果的支持。
- Fastly, Inc.（紐約證券交易所代碼：FSLY）上漲17％，至9.92美元。
- Nebius Group N.V.（納斯達克股票代碼：NBIS）股價上漲15.5％，至25.40美元，此前該公司宣佈與機構投資者簽訂了7億美元的私募融資協議。
- Enovix公司（納斯達克股票代碼：ENVX）上漲15.1％，至10.65美元。
- 澤塔環球控股公司（紐約證券交易所代碼：ZETA）上漲14.6％，至24.41美元。
- PTC Therapeutics, Inc.（納斯達克股票代碼：PTCT）上漲14.3％，至50.15美元，此前該公司宣佈與諾華簽署了其 PTC518 亨廷頓氏病計劃的全球被許可人和合作協議。
- 達納公司（紐約證券交易所代碼：DAN）上漲14％，至11.39美元，此前巴克萊將該股從等權重上調至增持，並將目標股價從12美元上調至18美元。
- 名創集團控股有限公司（紐約證券交易所代碼：MNSO）上漲12.9％，至22.60美元。該公司週五公佈了第一季度業績。
- Recursion Pharmicals, Inc.（納斯達克股票代碼：RXRX）上漲11.3％，至7.87美元。
- Akso Health Group（納斯達克股票代碼：AHG）上漲8.8％，至0.9000美元。
- Abercrombie & Fitch Co.紐約證券交易所代碼：ANF）上漲8.2％，至161.94美元。
- Merus N.V.（納斯達克股票代碼：MRUS）上漲8％，至48.43美元，此前該公司宣佈達成協議，獨家許可Ptx在美國將Zenocutuzumab（Zeno）商業化用於治療Nrg1 Fusion陽性癌症的權利。
- Gap, Inc.（紐約證券交易所代碼：GAP）上漲5.7％，至25.63美元，此前摩根大通將該股從中性上調至增持，並將目標股價從28美元上調至30美元。
Now Read This:
現在閱讀這篇文章：
- Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師對3只提供高股息收益率的金融股票發表了看法